Validation of gene signature

JC Jessica G. Cockburn
RH Robin M. Hallett
AG Amy E. Gillgrass
KD Kay N. Dias
TW T. Whelan
ML M. N. Levine
JH John A. Hassell
AB Anita Bane
request Request a Protocol
ask Ask a question
Favorite

To calculate a final prognostic index, gene Z scores were averaged by outcome association and then subtracted such that the average of poor outcome probesets was subtracted from the average of good outcome probesets, resulting in positive correlation to DMFS. Again, 10 year DMFS was used as the clinical endpoint and Cox PH Regression, C, and HRs were used to evaluate signature performance.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

0/150

tip Tips for asking effective questions

+ Description

Write a detailed description. Include all information that will help others answer your question including experimental processes, conditions, and relevant images.

post Post a Question
0 Q&A